Tigris names new chairman of the board
BONITA SPRINGS, Fla. A privately held drug maker that develops cancer treatments has appointed a new chairman of its board of directors.
Tigris Pharmaceuticals announced Thursday that it appointed Pedro Granadillo to the position. Granadillo has worked in the pharmaceutical industry for more than 30 years, including a term as SVP of Eli Lilly & Co., serving as on the Indianapolis-based drug maker’s executive committee and as head of human resources, manufacturing and quality.
“Pedro’s appointment as chairman of the board of directors will further expand his leadership role within our company and will play a key role in our partnering efforts and corporate strategy,” Tigris CEO Edmundo Muniz said in a statement. “We are pleased to have such a widely respected and experienced senior pharmaceutical executive chair our board of directors.”
Rite Aid appoints former executive to board of directors
CAMP HILL, Pa. Rite Aid on Wednesday named former executive David Jessick to its board of directors.
Jessick will fill the seat on the 14-member board vacated by George Golleher, who was elected in 2007 for a three-year term and has resigned. Golleher served on the board since 2002.
“George Golleher has been a hard-working member of our board for the past seven years, and we thank him for the many contributions he has made to our company,” stated Mary Sammons, Rite Aid chairman and CEO. “At the same time, we welcome Dave Jessick as a valuable addition, especially with his retail background and in-depth knowledge of Rite Aid.”
Jessick, 55, currently an independent investor, served Rite Aid as SVP, Chief Administrative Officer from December 1999 through July 2002. He then served as a consultant to Rite Aid’s CEO and senior management from July 2002 until February 2005. His more than 30 years of retail experience includes serving as CFO and EVP, finance and investor relations of Fred Meyer, a major northwest food and drug retailer, from January 1997 to July 1999. Prior to joining Fred Meyer, he spent 17 years with Thrifty Payless, a 1,000-store west coast drugstore chain, where he was EVP and CFO when Rite Aid acquired the company in 1996. Jessick also served as non-executive chairman of Pathmark Stores from August 2005 until December 2007, during the time that Rite Aid’s president and COO John Standley served as CEO of the grocer.
Jessick’s term will expire at the company’s annual meeting in June 2010, at which time he is expected to stand for re-election.
Jessick began his career as a Certified Public Accountant. He received a Bachelor of Business Administration degree in Accounting from Boise State University.
Weis Markets announces 90-day price freeze on 3,000 items
SUNBURY, Pa. Weis Markets on Wednesday announced it has implemented a second 90-day price freeze on 3,000 of its staple items, effective April 16 through July 15.
“At a time when unemployment continues to surge in many of our markets — in some areas to as high as 10% — our Price Freeze Program is designed to offer meaningful, long-term savings to our customers,” stated David Hepfinger, Weis Markets’ president and CEO. “We’ve also expanded our Price Freeze item count to 3,000 products, up 600 compared to our initial program. We estimate our initial Price Freeze program helped our customers save approximately $5 million and hope to save our customers even more in the coming months.”
Of the 3,000 Price Freeze products, Weis Markets first lowered the prices on 2,400 items – and then froze this lower price for 90 days.
The current price freeze program includes private label and brand name products in center store, frozen, dairy, produce, meat, deli and bakery. The Price Freeze program is being promoted in Weis Markets’ current print, television and radio ads. In stores, customers will see special Price Freeze shelf tags on participating items.